Patents by Inventor Michael A Garff

Michael A Garff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for diagnosing a malignant lung tumor
    Patent number: 10117596
    Abstract: A method to determine presence of a disease condition in a medical patient by evaluating conductivity information. Point-attributes values obtained from highly accurate conductivity data-sets taken as a function of time, over a period of time, are compared to previously determined threshold values. Z-scores may be determined to combine a plurality of point-attribute values in formulation of a composite score for a patient. Sometimes, z-scores are weighted by overall accuracy of the point-attribute in predicting presence of the disease.
    Type: Grant
    Filed: August 19, 2013
    Date of Patent: November 6, 2018
    Assignee: PROLUNG, INC.
    Inventors: Steven C Eror, Michael A Garff
  • METHOD FOR DIAGNOSING A MALIGNANT LUNG TUMOR
    Publication number: 20150051504
    Abstract: A method to determine presence of a disease condition in a medical patient by evaluating conductivity information. Point-attributes values obtained from highly accurate conductivity data-sets taken as a function of time, over a period of time, are compared to previously determined threshold values. Z-scores may be determined to combine a plurality of point-attribute values in formulation of a composite score for a patient. Sometimes, z-scores are weighted by overall accuracy of the point-attribute in predicting presence of the disease.
    Type: Application
    Filed: August 19, 2013
    Publication date: February 19, 2015
    Applicant: Fresh Medical Laboratories, Inc.
    Inventors: Steven C Eror, Michael A Garff